Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases

被引：0
|
作者：
Zhenhong Wang
Jian An
Chaohua Wang
机构：
[1] Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics,Department of Gynecology
[2] Fujian Medical University,Department of Gynecology, Women and Children’s Hospital, School of Medicine
[3] Xiamen University,Department of Gynecology and Obstetrics
[4] Peking University People’s Hospital,undefined
来源：
BMC Women's Health | / 22卷
关键词：
Chemotherapy; Premature ovarian failure; Perimenopausal symptoms; Myeloablative regimen; Leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 33 条
  • [1] Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases
    Wang, Zhenhong
    An, Jian
    Wang, Chaohua
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [2] Phase II Study of Gonadotropin-Releasing Hormone Analog for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
    Cheng, Yee Chung
    Takagi, Mariko
    Milbourne, Andrea
    Champlin, Richard E.
    Ueno, Naoto T.
    ONCOLOGIST, 2012, 17 (02) : 233 - 238
  • [3] Gonadotropin-Releasing Hormone Analog Cotreatment for Preservation of Ovarian Function
    Blumenfeld, Zeev
    ONCOLOGIST, 2012, 17 (02) : 162 - 163
  • [4] Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy
    Gilan, Mitra Modares
    Hasanzadeh, Malihe
    Ghaemmaghami, Faterneh
    Ramazanzadeh, Faterneh
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2007, 3 (02) : 79 - 83
  • [5] Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation
    Blumenfeld, Zeev
    Patel, Biren
    Leiba, Ronit
    Zuckerman, Tsila
    FERTILITY AND STERILITY, 2012, 98 (05) : 1266 - +
  • [6] Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogs
    Blumenfeld, Zeev
    WOMENS HEALTH, 2011, 7 (06) : 635 - 640
  • [7] Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy
    Kim, Hee Jeong
    Lee, Moo Hyun
    Lee, Jeong Eon
    Park, Seho
    Lee, Eun Sook
    Kang, Yong Joon
    Shin, Hae Na
    Kim, Seung Il
    Lee, Jun Ho
    Im, Seock Ah
    Ahn, Sei Hyun
    Lee, Keun Seok
    Sohn, Joohyuk
    Kim, Seonok
    Nam, Seok Jin
    Han, Wonshik
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1165 - E1172
  • [8] Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?
    Blumenfeld, Zeev
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1895 - +
  • [9] Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist
    Ozcelik, Bulent
    Turkyilmaz, Cagdas
    Ozgun, Mahmut Tuncay
    Serin, Ibrahim Serdar
    Batukan, Cem
    Ozdamar, Saim
    Ozturk, Ahmet
    FERTILITY AND STERILITY, 2010, 93 (05) : 1609 - 1614
  • [10] Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation
    Han, Ruxue
    Song, Ziyi
    Li, Huiling
    Wang, Chaohua
    Zhang, Leping
    Yang, Xin
    SCIENTIFIC REPORTS, 2023, 13 (01)
1234